with established CVD and LDL-C ≥70 mg/dL and/or non-HDL-C ≥100 mg/dL despite high- or moderate-intensity statin therapy. This protein stops your body from getting rid of low-density lipoprotein (LDL) cholesterol.
Patients received either subcutaneous injections of Repatha (140 mg every 2 weeks or 420 mg once monthly) or placebo. FOURIER was a double-blind, randomized, placebo-controlled, event-driven trial. This activity reviews the indications, mechanism of action, contraindications, adverse effects. The ultimate goal of this therapy is to normalize a compromised immune system. Intravenous immunoglobulin (IVIG) is a pooled antibody, and a biological agent used to manage various immunodeficiency states and a plethora of other conditions, including autoimmune, infectious, and inflammatory states. Also tell your doctor if you are allergic to rubber or latex. Official answer by One serious danger of taking Repatha (evolocumab) is a possibly life-threatening allergic reaction to the active ingredient.
FAQ Are there any dangers of taking Repatha? Medically reviewed by Leigh Ann Anderson, PharmD.Repatha mechanism of action As an adjunct to diet, alone or in combination with other low-density lipoprotein cholesterol (LDL-C)-lowering therapies, in adults with primary hyperlipidemia, including heterozygous familial hypercholesterolemia (HeFH) to reduce LDL-C REPATHA SAFETY PROFILE Across more than 26,000 patients, Repatha demonstrated a consistent safety profile
0 kommentar(er)
